Austar Lifesciences Limited AULSF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.29% | 0.85% | 109.39% | 233.87% | 152.06% |
| Total Depreciation and Amortization | -7.78% | -8.26% | -8.77% | -2.78% | 4.08% |
| Total Amortization of Deferred Charges | -0.29% | 2.14% | 4.67% | 2.38% | 0.77% |
| Total Other Non-Cash Items | 1,258.23% | 685.51% | 101.98% | -89.75% | -96.32% |
| Change in Net Operating Assets | 59.32% | 59.32% | 59.32% | 161.95% | 119.36% |
| Cash from Operations | 57.99% | 46.92% | 34.12% | 107.08% | 445.20% |
| Capital Expenditure | -32.89% | -23.83% | -12.75% | 18.97% | 34.78% |
| Sale of Property, Plant, and Equipment | -88.18% | -88.44% | -88.68% | 4.84% | 5,645.83% |
| Cash Acquisitions | -- | -- | -- | -0.51% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.59% | -67.10% | -50.67% | -52.78% | -54.50% |
| Cash from Investing | -221.83% | -644.43% | -397.39% | -92.01% | 35.80% |
| Total Debt Issued | 2.42% | 15.15% | 28.57% | 5.46% | -13.51% |
| Total Debt Repaid | -6.92% | -9.40% | -11.88% | -12.30% | -12.77% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 18.11% | 17.54% | 17.06% | 13.55% | 9.89% |
| Cash from Financing | -24.92% | 12.50% | 42.95% | -51.87% | -1,077.05% |
| Foreign Exchange rate Adjustments | -618.27% | -325.00% | -158.34% | -100.57% | 69.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.91% | 278.80% | 1,837.49% | 396.84% | 77.53% |